University of Tasmania, Menzies Institute for Medical Research, Hobart, TAS, Australia.
Centre for Health Economics, Monash University, VIC, Australia.
Qual Life Res. 2023 Feb;32(2):553-568. doi: 10.1007/s11136-022-03214-y. Epub 2022 Aug 29.
Multiple sclerosis (MS) is an inflammatory, neurodegenerative disease of the central nervous system which results in disability over time and reduced quality of life. To increase the sensitivity of the EQ-5D-5L for psychosocial health, four bolt-on items from the AQoL-8D were used to create the nine-item EQ-5D-5L-Psychosocial. We aimed to externally validate the EQ-5D-5L-Psychosocial in a large cohort of people with MS (pwMS) and explore the discriminatory power of the new instrument with EQ-5D-5L/AQoL-8D.
A large representative sample from the Australian MS Longitudinal Study completed the AQoL-8D and EQ-5D-5L (including EQ VAS) and both instruments health state utilities (HSUs) were scored using Australian tariffs. Sociodemographic/clinical data were also collected. External validity of EQ-5D-5L-Psychosocial scoring algorithm was assessed with mean absolute errors (MAE) and Spearman's correlation coefficient. Discriminatory sensitivity was assessed with an examination of ceiling/floor effects, and disability severity classifications.
Among 1683 participants (mean age: 58.6 years; 80% female), over half (55%) had moderate or severe disability. MAE (0.063) and the distribution of the prediction error were similar to the original development study. Mean (± standard deviation) HSUs were EQ-5D-5L: 0.58 ± 0.32, EQ-5D-5L-Psychosocial 0.62 ± 0.29, and AQoL-8D: 0.63 ± 0.20. N = 157 (10%) scored perfect health (i.e. HSU = 1.0) on the EQ-5D-5L, but reported a mean HSU of 0.90 on the alternative instruments. The Sleep bolt-on dimension was particularly important for pwMS.
The EQ-5D-5L-Psychosocial is more sensitive than the EQ-5D-5L in pwMS whose HSUs approach those reflecting full health. When respondent burden is taken into account, the EQ-5D-5L-Psychosocial is preferential to the AQoL-8D. We suggest a larger confirmatory study comparing all prevalent multi-attribute utility instruments for pwMS.
多发性硬化症(MS)是一种中枢神经系统的炎症性、神经退行性疾病,随着时间的推移会导致残疾和生活质量下降。为了提高 EQ-5D-5L 在社会心理健康方面的敏感性,使用 AQoL-8D 的四个附加项创建了包含九个项目的 EQ-5D-5L-Psychosocial。我们旨在通过对大量多发性硬化症患者(pwMS)进行外部验证,以及与 EQ-5D-5L/AQoL-8D 一起探索新工具的鉴别力,来验证 EQ-5D-5L-Psychosocial 的有效性。
澳大利亚多发性硬化症纵向研究的一个大型代表性样本完成了 AQoL-8D 和 EQ-5D-5L(包括 EQ VAS),并使用澳大利亚关税对两种工具的健康状态效用(HSU)进行了评分。还收集了社会人口统计学/临床数据。使用平均绝对误差(MAE)和斯皮尔曼相关系数评估 EQ-5D-5L-Psychosocial 评分算法的外部有效性。通过检查天花板/地板效应和残疾严重程度分类,评估鉴别敏感性。
在 1683 名参与者中(平均年龄:58.6 岁;80%为女性),超过一半(55%)有中度或重度残疾。MAE(0.063)和预测误差的分布与原始开发研究相似。EQ-5D-5L 的平均(±标准差)HSU 为 0.58 ± 0.32,EQ-5D-5L-Psychosocial 为 0.62 ± 0.29,AQoL-8D 为 0.63 ± 0.20。有 157 名参与者(10%)在 EQ-5D-5L 上获得了完美健康评分(即 HSU=1.0),但在替代工具上报告的平均 HSU 为 0.90。睡眠附加维度对 pwMS 尤其重要。
在接近完全健康的 HSU 的 pwMS 中,EQ-5D-5L-Psychosocial 比 EQ-5D-5L 更敏感。当考虑到受访者的负担时,EQ-5D-5L-Psychosocial 比 AQoL-8D 更受欢迎。我们建议进行一项更大的验证性研究,比较所有流行的多属性效用工具在 pwMS 中的应用。